Antidepressants enhance the antinociceptive effects of carbamazepine in the acetic acid-induced writhing test in mice

被引:24
作者
Aoki, Mieko
Tsuji, Minoru
Takeda, Hiroshi
Harada, Yoichiro
Nohara, Jun
Matsumiya, Teruhiko
Chiba, Hiroshige
机构
[1] Tokyo Med Univ, Dept Oral & Maxillofacial Surg, Shinjuku Ku, Tokyo 1600023, Japan
[2] Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, Tokyo 1608402, Japan
[3] Int Univ Hlth & Welf, Sch Pharmaceut Sci, Div Pharmacol, Ohtawara, Tochigi 3248501, Japan
关键词
imipramine; fluvoxamine; milnacipran; carbamazepine; writhing test; (mouse);
D O I
10.1016/j.ejphar.2006.08.049
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Some antidepressants, as well as antiepileptics, are effective for treating pain of varying etiology. The present study was designed to characterize the antinociceptive effects of imipramine, a tricyclic antidepressant, fluvoxamine, a selective serotonin reuptake inhibitor, milnacipran, a serotonin noradrenaline reuptake inhibitor, and carbamazepine, an antiepileptic drug, using the acetic acid-induced writhing test in mice. Imipramine (1.25-10 mg/kg, i.p.), fluvoxamine (5-40 mg/kg, i.p.) and milnacipran (2.5-20 mg/kg, i.p.) all dose-dependently and significantly reduced the number of writhes induced by the injection of acetic acid (0.8% (v/v)), although the maximal effect of milnacipran was weaker than those of imipramine and fluvoxamine. Similarly, carbamazepine (5-20 mg/kg, i.p.) also showed a dose-dependent and significant antinociceptive effect. In combination studies, the co-administration of a sub-effective dose of carbamazepine (5 mg/kg, i.p.) with imipramine (1.25 and 2.5 mg/kg, i.p.), fluvoxamine (10 mg/kg, i.p.) or milnacipran (1.25 and 2.5 mg/kg, i.p.) significantly reduced the number of writhes. Additionally, the hole-board test revealed that the medications with significant antinociceptive effects barely produced changes in motor activity that could possibly affect writhing behavior. Thus, the present study demonstrated that the antinociceptive effect of carbamazepine is enhanced by combination with imipramine, fluvoxamine and milnacipran. Therefore, the combined therapy using antidepressants and carbamazepine may be useful clinically for the control of pain. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:78 / 83
页数:6
相关论文
共 44 条
[31]   Antinociceptive effects of sodium channel-blocking agents on acute pain in mice [J].
Sakaue, A ;
Honda, M ;
Tanabe, M ;
Ono, H .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 95 (02) :181-188
[32]   The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms [J].
Schreiber, S ;
Backer, MM ;
Pick, CG .
NEUROSCIENCE LETTERS, 1999, 273 (02) :85-88
[33]   Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action [J].
Sindrup, SH ;
Jensen, TS .
PAIN, 1999, 83 (03) :389-400
[34]   Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs [J].
Spina, E ;
Perucca, E .
EPILEPSIA, 2002, 43 :37-44
[35]   Understanding pain in depression [J].
Stahl, S ;
Briley, M .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 :S9-S13
[36]   The anti-nociceptive agent ralfinamide inhibits tetrodotoxin-resistant and tetrodotoxin-sensitive Na+ currents in dorsal root ganglion neurons [J].
Stummann, TC ;
Salvati, P ;
Fariello, RG ;
Faravelli, L .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 510 (03) :197-208
[37]   Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression [J].
Szymura-Oleksiak, J ;
Wyska, E ;
Wasieczko, A .
PSYCHOPHARMACOLOGY, 2001, 154 (01) :38-42
[38]   Effects of a 5-HT7 receptor antagonist DR4004 on the exploratory behavior in a novel environment and on brain monoamine dynamics in mice [J].
Takeda, H ;
Tsuji, M ;
Ikoshi, H ;
Yamada, T ;
Masuya, J ;
Iimori, M ;
Matsumiya, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 518 (01) :30-39
[39]   Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice [J].
Takeda, H ;
Tsuji, M ;
Matsumiya, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 350 (01) :21-29
[40]   The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists [J].
Tomic, MA ;
Vuckovic, SM ;
Stepanovic-Petrovic, RM ;
Ugresic, N ;
Prostran, MS ;
Boskovic, B .
PAIN, 2004, 111 (03) :253-260